Literature DB >> 27234271

Helicobacter pylori Gastritis: Susceptible to Further Testing?

Beverly B Rogers1, Benjamin D Gold2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27234271     DOI： 10.1007/s10620-016-4200-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  19 in total

1.  Helicobacter pylori.

Authors:  Jacob J Rosenberg
Journal:  Pediatr Rev       Date:  2010-02

Review 2.  Twenty five years since the first prospective study by Forman et al. (1991) on Helicobacter pylori and stomach cancer risk.

Authors:  Freddy Sitas
Journal:  Cancer Epidemiol       Date:  2016-02-26       Impact factor: 2.984

3.  Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.

Authors:  J Versalovic; M S Osato; K Spakovsky; M P Dore; R Reddy; G G Stone; D Shortridge; R K Flamm; S K Tanaka; D Y Graham
Journal:  J Antimicrob Chemother       Date:  1997-08       Impact factor: 5.790

4.  Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.

Authors:  V Y Miendje Deyi; V Y Miendje Deyi; P Bontems; J Vanderpas; E De Koster; R Ntounda; C Van den Borre; S Cadranel; A Burette
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

5.  Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

Authors:  Joette M Meyer; Nancy P Silliman; Wenjin Wang; Nancy Y Siepman; Jennifer E Sugg; David Morris; Jie Zhang; Helen Bhattacharyya; Eileen C King; Robert J Hopkins
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

Review 6.  Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe.

Authors:  S E Roberts; S Morrison-Rees; D G Samuel; K Thorne; A Akbari; J G Williams
Journal:  Aliment Pharmacol Ther       Date:  2015-11-23       Impact factor: 8.171

7.  Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.

Authors:  Francis Megraud; Samuel Coenen; Ann Versporten; Manfred Kist; Manuel Lopez-Brea; Alexander M Hirschl; Leif P Andersen; Herman Goossens; Youri Glupczynski
Journal:  Gut       Date:  2012-05-12       Impact factor: 23.059

8.  Environmental risk factors associated with Helicobacter pylori seroprevalence in the United States: a cross-sectional analysis of NHANES data.

Authors:  W S Krueger; E D Hilborn; R R Converse; T J Wade
Journal:  Epidemiol Infect       Date:  2015-01-16       Impact factor: 4.434

Review 9.  Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.

Authors:  Bao-Zhu Li; Diane Erin Threapleton; Ji-Yao Wang; Jian-Ming Xu; Jin-Qiu Yuan; Chao Zhang; Peng Li; Qian-Ling Ye; Biao Guo; Chen Mao; Dong-Qing Ye
Journal:  BMJ       Date:  2015-08-19

10.  Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States.

Authors:  William M Duck; Jeremy Sobel; Janet M Pruckler; Qunsheng Song; David Swerdlow; Cindy Friedman; Alana Sulka; Balasubra Swaminathan; Tom Taylor; Mike Hoekstra; Patricia Griffin; Duane Smoot; Rick Peek; David C Metz; Peter B Bloom; Steven Goldschmidt; Julie Parsonnet; George Triadafilopoulos; Guillermo I Perez-Perez; Nimish Vakil; Peter Ernst; Steve Czinn; Donald Dunne; Ben D Gold
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.